Stay updated on ONC201 + Nivolumab in MSS mCRC Clinical Trial
Sign up to get notified when there's something new on the ONC201 + Nivolumab in MSS mCRC Clinical Trial page.

Latest updates to the ONC201 + Nivolumab in MSS mCRC Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov footer now shows revision v3.8.0 instead of v3.7.2; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check7 days agoChange DetectedAn NIH announcement banner was added, describing a terminology change from “Artificial Intelligence” to “Super Intelligence” and linking to transition updates and FAQs.SummaryDifference1%

- Check14 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check21 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check43 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the study content, replacing the previously visible details with a standard error page and blocking access to study information and related resources.SummaryDifference19%

- Check64 days agoChange DetectedThe revision tag on the study record was updated from v3.6.5 to v3.6.6, indicating an administrative update to the page history. This change does not alter the study data or how the trial details are presented.SummaryDifference0.1%

Stay in the know with updates to ONC201 + Nivolumab in MSS mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ONC201 + Nivolumab in MSS mCRC Clinical Trial page.